Geographical variance in the risk of gastric stump cancer: no increased risk in Japan?

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 1827091)

Published in Jpn J Cancer Res on March 01, 1991

Authors

A C Tersmette1, F M Giardiello, G J Offerhaus, K W Tersmette, K Ohara, J P Vandenbroucke, G N Tytgat

Author Affiliations

1: Department of Clinical Epidemiology, University Hospital Leiden, The Netherlands.

Articles citing this

Risk of gastric remnant cancer in Japan. Jpn J Cancer Res (1991) 0.75

Articles by these authors

Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70

Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet (1990) 9.49

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73

Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis (1989) 6.52

Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol (2001) 6.30

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet (1994) 5.58

Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27

Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med (1995) 5.16

Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol (1986) 5.15

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet (1995) 5.10

Genetic influence on cytokine production and fatal meningococcal disease. Lancet (1997) 4.89

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86

The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69

Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet (1993) 4.55

Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39

QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation (1991) 4.37

Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology (1989) 4.23

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ (2009) 4.18

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet (1992) 4.15

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med (1996) 4.11

Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08

Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet (1995) 4.01

Functional gastroduodenal disorders. Gut (1999) 3.74

Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet (1994) 3.69

The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59

Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet (1992) 3.58

K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol (1993) 3.56

Case reports in an evidence-based world. J R Soc Med (1999) 3.55

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22

Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet (1997) 3.12

Needle-knife sphincterotomy as a precut procedure: a retrospective evaluation of efficacy and complications. Endoscopy (1996) 3.12

Is publication bias a medical problem? Lancet (1993) 3.04

Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol (1989) 3.02

The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02

High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood (1995) 2.96

Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med (1991) 2.93

Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology (2001) 2.85

Collagenous colitis with mucosal tears on endoscopic insufflation: a unique presentation. Gut (2002) 2.81

Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77

Recurrent massive haematemesis from Dieulafoy vascular malformations--a review of 101 cases. Gut (1986) 2.74

Regular review: treatment of Helicobacter pylori infection. BMJ (2000) 2.73

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73

Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med (1993) 2.70

An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol (1994) 2.67

The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis (1996) 2.66

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ (1994) 2.54

Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc (1996) 2.54

How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49

Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group. Lancet (1998) 2.42

Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol (1993) 2.40

Osteoarthritis and obesity in the general population. A relationship calling for an explanation. J Rheumatol (1988) 2.39

Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res (1993) 2.39

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38

Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol (1984) 2.38

Antipsychotic medication and venous thrombosis. Br J Psychiatry (2001) 2.37

The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology (1999) 2.37

Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet (1991) 2.31

Bungee-jumping and design of experiments. Lancet (1992) 2.31

Mortality in hereditary antithrombin-III deficiency--1830 to 1989. Lancet (1991) 2.31

Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet (1996) 2.30

K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res (1996) 2.29

Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. JAMA (1989) 2.29

Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter (1996) 2.26

Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood (2000) 2.24

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res (1998) 2.23

Collagenous sprue--an unrecognized type of malabsorption. N Engl J Med (1970) 2.21

Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys (2000) 2.21

New public health and old rhetoric. BMJ (1994) 2.18

Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol (1997) 2.18

Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology (1996) 2.17

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther (1999) 2.14

Treatment of bile duct lesions after laparoscopic cholecystectomy. Gut (1996) 2.12

The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet (2004) 2.10

Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China. J Infect Dis (1998) 2.09

Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) Blood (1995) 2.09

Desmoid tumours in familial adenomatous polyposis. Gut (1994) 2.08

Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation (1990) 2.07

Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology (1978) 2.07

No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: the Leiden 85-plus study. Eur J Clin Invest (2002) 2.07

Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis (1990) 2.07

[Changed diagnosis and treatment of hepatocellular carcinoma]. Ned Tijdschr Geneeskd (1996) 2.04

Psychiatric disorders in relation to medical illness among patients of a general medical out-patient clinic. Psychol Med (1993) 2.01

Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum (1990) 2.01

Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands. Lancet (1996) 1.99

Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98

Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol (1987) 1.97

Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut (1992) 1.96

Ultrasound biomicroscopy of ciliary body cysts. Am J Ophthalmol (1999) 1.96

Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med (1999) 1.95

HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut (1999) 1.94